LB-20 Medical Cyclotron: A High-Energy Platform for Large-Scale Radionuclide Production

2026-03-12

LB-20 Medical Cyclotron: A High-Energy Platform for Large-Scale Radionuclide Production

The LB-20https://www.chinacyclotron.com/cyclotron-lb-20-product/ medical cyclotron is a high-energy cyclotron platform developed by Longevous Beamtech (LBT🌐 www.chinacyclotron.com) to support large-scale radionuclide production for modern nuclear medicine facilities, and is variable at 14 MeV and 20 MeV energy levels to maximize the yield of different isotopes.

Designed for institutions requiring expanded isotope production capability, the LB-20 supports both routine clinical radionuclide production and advanced nuclear medicine research applications. With flexible target configurations and scalable production capability, the platform is suitable for large hospitals, regional imaging centers, research institutes, and radiopharmaceutical manufacturers.

🔹 Multi-Target Compatibility for Diverse Radionuclide Production

The LB-20 supports liquid, gas, and optional solid target systems, enabling the production of a wide range of radionuclides used in clinical imaging and scientific research.

Representative radionuclides include: ¹⁸F, ¹¹C, ¹³N, ⁶⁸Ga, ⁶⁴Cu, ⁶¹Cu, ⁸⁹Zr, ¹²⁴I, ⁹⁹ᵐTc, ¹¹¹In, ⁴⁴Sc, as well as other emerging radionuclides used in molecular imaging and radiopharmaceutical research.

🔹 High-Capacity Production for Clinical and Regional Supply

The LB-20 is designed to support high-capacity radionuclide production for medical institutions and regional radiopharmaceutical supply networks.

The system enables the production of larger radionuclide batches suitable for supplying multiple PET imaging centers or nuclear medicine departments.

Engineering design focuses on:

• Stable beam operation

• Efficient target thermal management

• Optimized production workflows

• Long-term operational reliability

🔹 Solid Target Expansion for Advanced Radionuclide Applications

The LB-20 can be equipped with optional solid target systems and supporting processing modules to enable the production of metallic radionuclides.

Through the IsotopeX-Lab https://www.chinacyclotron.com/isotopex-lab-product/ solid target platform, multiple target transfer solutions support automated transfer and processing within shielded environments.

This configuration enables institutions to explore radionuclides used in:

• Immuno-PET imaging

• Radiopharmaceutical research

• Targeted radionuclide therapy development

The modular design also allows future upgrades without major modification of existing facility layouts, providing long-term flexibility for nuclear medicine programs.